Areas of Activity

Contact us

Updates

Santiago de Chile, September 2010 - DirexGroup participated at the 30th Annual meeting of the Confederation of American Urology which was held at the Sheraton San Cristobal Conference Center between September 8 and 11. DirexGroup's presence has, once again, reinforced its strong presence in the Andean market.  Along with its local distributor, Otarola Ingenieria, Direx presented to physicians and visitors its wide range of electromagnetic ESWL lithotripters, including the Magna and Integra systems, plus their latest 20W Holmium Laser device.

Dr. Sandro Varea, Head of the Department of Urology at Hospital Privado in Mar del Plata, Argentina, and one of our key reference sites in the region, presented his initial treatment results with the Dual Shockwave MAGNA lithotripter in patients suffering from litiacis.  After treating several patients using MAGNA's electromagnetic device with the double shockwave technology, Dr. Varea presented promising results; thereby attracting much physician audience attention with his presentation.  "The double shockwave treatment is a safe and effective procedure" said Dr. Varea.  (click here to download the presentation)

The Congress was an excellent venue to meet many Latin American Direx users - users whom DirexGroup has provided lithotripsy systems and services for many years.

About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology devices for urologists in all worldwide markets.  DirexGroup, established over 20 years ago, has continuously extended its worldwide presence in numerous countries and markets.  DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs.  Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use.  Worldwide network of committed service centers assure adequate support and maintenance.  Contact DirexGroup at This email address is being protected from spambots. You need JavaScript enabled to view it..

LEIDEN, THE NETHERLANDS - DirexGroup Germany, a distributor of Initia Medical products in Europe, announced today an agreement with Mayumana Healthcare as their sales and service partner for the Netherlands. This agreement expands the reach of DirexGroup and is in keeping with their philosophy of local representation and service in the coutnries they serve.

"We have been making great progress in expanding the distribution of our products into Europe" stated Niv Ein-Gal, Chief Operating Officer for DirexGroup.  "We reviewed the market thoroughly for potential partners and Mayumana Healthcare was the obvious choce to achieve the level of service we seek to deliver to our customers."

Mayumana Healthcare introduces innovative new products in urology, gynecology and general surgery in the Benelux and Euorpean markets.  "This new relationship with Direx really rounds out our urology offering: reported Bart Verleg, CEO of Mayumana Healthcare.  "Direx provides top quality products with a sensitivity towards our customers financial capabilities. Their productc, coupled with Mayumana's services, will be a strong fit for the markets we serve."

Together the companies are offering a strong suite of urological products including the Smart 2100 holmium laser, the Duet Magna lithotripter, which has already gained favor in the Belgium market, and Tempro for the treatment of prostatitis. To launch the partnership, the companies have planned a variety of introductory offers and services which will be very attractive for customers.  "While providing products in over 70 countries worldwide, Direx is relatively new in this market and so we will be very aggressive in our offers to customers to win their business" stated Mr. Verleg. "I believe customers will be surprised at the value we have been able to achieve through aggressive pricing and dedicated, local service. As in other markets, we expect our products to be part of many customers' treatment venues in the very near future.

DirexGroup is a worldwide manufacturer of urological equipment serving over 70 countries around the world.  Known for their groundbreaking Tripter X-1 developed in 1986, Direx equipment eventually became the standard in the industry.  A collaboration with Initia (Medical Technologies) has resulted in many of the more interesting developments in ESWL in recent years.  Find out more at www.direxgroup.com.

 Mayumana Healthcare is a full service-oriented distributor of urological and gynecological products. Find out more about Mayumana Healthcare at www.mayumana-healthcare.com

Urologists from Europe gathered together in Dortmund, Germany to participate in a seminar operating the Tempro thermotherapy system for chonic prostatitis treatment.  The seminar included frontal presentations and discussions held by various urologists with thermal therapy experience.
The  participating physicians were then invited to partake in  several clinical treatment sessions emphasizing the ease and simplicity of  the  Tempro device 's application.  The session provided the  participants a relevant platform for sharing their own knowledge  from various European environments  and experience with CPPS and thermal application.  The seminar was summarized successfully and more such events are in the planning stage in various European and worldwide locations.

 

About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology treatment devices for urologists in all worldwide markets. DirexGroup, established over 20 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and services solutions to their clinical and economic needs. Our products are characterized by reliability, modularity, and transportability combined with cost effectiveness and ease of use. Worldwide network of committed service centers assure adequate support and maintenance.

 Contact DirexGroup at This email address is being protected from spambots. You need JavaScript enabled to view it.
DirexGroup made a strong showing at the AFU which took place in Palais des Congres in Paris from November 18 to 21. Direx’s participation signifies its renewed surge in the French market, where they offered its newest line of electromagnetic ESWL systems – modular Magna and the integrated Integra devices, as well as the 20W holmium laser. “The offer of the two newest electromagnetic devices allows for maximum compatibility for our customers. The Magna is at the technological front of modular systems, allowing hospitals to choose various X-ray and ultrasound imaging options, as well as urological applications compatibility. The Integra is the best suited unit in the market for ESWL dedicated (integrated) systems for hospitals with large patient loads and need for quick and easy set-up and application.” announced Jean Claude Lavenu, DirexGroup's representative in the French market. 

About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology treatment devices for urologists in all worldwide markets. DirexGroup, established over 20 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and services solutions to their clinical and economic needs. Our products are characterized by reliability, modularity, and transportability combined with cost effectiveness and ease of use. Worldwide network of committed service centers assure adequate support and maintenance.

 Contact DirexGroup at This email address is being protected from spambots. You need JavaScript enabled to view it.

 

The first UK paper on the use of Double Shock Wave Lithotripsy was presented at the World Congress of Endourology from October 6-10 in Germany.  Dual Electro Hydraulic Lithotripsy safety and efficacy was further reinforced by updated clinical data submitted by Darrent Valley Hospital, Dartford UK. The Dartford NHS hospital replaced its mobile service for a permanent lithotripter, in accordance with their commitment “to providing high quality medical and nursing care, making every effort to ensure that our patients receive the very best treatment, attention and care.”
Initial treatments were with an Electro hydraulic version of Dual Shockwave Lithotripsy and in the last six months treatment was administered by Magna, the newest Electromagnetic Dual Shockwave Lithotripter by DirexGroup.
 

A second paper was presented by Dr CH. Beck and Dr. A. Beck on Tempro BiPolar Radio Frequency for Chronic Prostatitis.   This is  a new application of  Tempro  Bipolar Radio  Frequency technology  to tackle a very complex medical  condition which leads to poor quality of life. Their supportive conclusion is “Considering that Chronic Prostatitis is a challenging illness, these initial results, with an overall success rate of 43% are very encouraging”.  Following this initial success, additional Tempro centers have started to offer this innovative treatment for their patients.  

About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology treatment devices for urologists in all worldwide markets. DirexGroup, established over 20 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and services solutions to their clinical and economic needs. Our products are characterized by reliability, modularity, and transportability combined with cost effectiveness and ease of use. Worldwide network of committed service centers assure adequate support and maintenance.

 Contact DirexGroup at  This email address is being protected from spambots. You need JavaScript enabled to view it.

Direxgroup will launch its newest developments, the electromagnetic Duet Magna lithotripter and the Tempro RF thermal therapy system , at the BAUS congress to be held at the Scottish Exhibition and Conference Centre (SECC), Glasgow, from June 23-25, 2009.

Duet Magna is a unique lithotripter combining two shockwave sources and electromagnetic technology. The Magna DSWL (Double Shock Wave Lithotripsy), produces a unique "Butterfly" Focal Volume proven to reduce significantly kidney damage compared to all single source lithotripters which produce "Cigar Shaped" Focal Volume. In Cigar shaped Focal Volumes, only the central part contributes to stone fragmentation  whereas the distal and proximal areas contribute only to kidney damage. The Butterfly focal area is a closer approximation to a spherical focal area which is the Ideal Focal Volume to treat stones.  In addition, DSWL divides the total energy reaching the stone into two different volumes, so that half of the energy reaches the stone from an Upper Volume while the second half comes from a Lower Volume. 
Direx introduces Chronic Abacterial Prostatitis / CPPS  treatment with Tempro Thermotherapy System.  Tempro, a thermal therapy device that treats symptomatic BPH and Prostatitis, provides prostate thermal heating by delivering Radio Frequency  power to the prostate tissue, via an applicator located in the Prostatic urethra. A  computer controlled Bipolar RF generator delivers its power to a special multi-electrode applicator. Safety is assured by measuring  continuously the maximum temperature using 3 sensors.  

Chronic Abacterial Prostatitis / CPPS is a common, bothersome syndrome in men which is poorly defined, poorly understood, and poorly treated. 

Direx-Initia started an effort for treatment of this illness using thermal

therapy and is presently conducting a multi-site study for Chronic 

Abacterial Prostatitis patients at centers in Europe and Asia. 

The NIH Chronic Prostatitis Symptom Index and the Quality of Life

Index are used to evaluate the severity of symptoms and further

improvements. Initial results are encouraging and will be presented

at the upcoming EAU Congress in Stockholm March 17 to 20. 

Tempro, a thermal therapy device that treats symptomatic BPH and 

Prostatitis, provides prostate thermal heating by delivering Radio Frequency 

power to the prostate tissue, via an applicator located in the Prostatic urethra. 

 computer controlled Bipolar RF generator delivers its power to a special

multi-electrode applicator. Safety is assured by measuring continuously the

maximum temperature using 3 sensors.  


 

DirexGroup exhibited at the World Congress of Endourology 2008 in Shanghai. During this venue, Direx approached the Chinese market with two innovative systems: The Duet lithotripter and the Tempro for BPH treatment.

The Duet lithotripter uses an innovative and unique Dual Shock Wave technology. Recent research at Indiana University shows that this technology not only allows treatment at 240 shocks/min, thus reducing treatment time by half, but also reduces kidney damage at least 5 times compared to similar treatment with a single reflector.

Tempro allows for an innovative BPH treatment using a Bipolar Radio Frequency Multielectrode on a 16 Foley catheter. The Bipolar technology allows localized treatment around the urethra with maximum safety to rectum and external sphincter.


About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology treatment devices for urologists in all worldwide markets. DirexGroup, established over 20 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and services solutions to their clinical and economic needs. Our products are characterized by reliability, modularity, and transportability combined with cost effectiveness and ease of use. Worldwide network of committed service centers assure adequate support and maintenance

Contact DirexGroup at This email address is being protected from spambots. You need JavaScript enabled to view it.  

Direx Japan successfully launches the Electromagnetic Integra, a device specially designed for the specific needs of the Japanese market. The Integra has a "Super Compact" design for ideal installation in small treatment rooms. The Shock Wave Generator, X-ray Fluoroscopy and Table are integrated in a single compact unit.

The Integra has a unique X-ray In-line Localization system with its inherent advantage - no need of "air bags". Direx's unique Air Duct technology allows localization without having to stop the treatment.

About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology treatment devices for urologists in all worldwide markets. DirexGroup, established over 20 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and services solutions to their clinical and economic needs. Our products are characterized by reliability, modularity, and transportability combined with cost effectiveness and ease of use. Worldwide network of committed service centers assure adequate support and maintenance

Contact DirexGroup at This email address is being protected from spambots. You need JavaScript enabled to view it.

Following CE approval and successful use of the Tempro system in Europe, Direx Korea recently received approval for the device by Korean Food and Drug Administration.

Tempro, an innovative system treating BPH, uses a Bipolar Radio Frequency technology. A Multielectrode Applicator on a 16 Foley catheter is used during treatment. The Bipolar technology allows localized treatment around the urethra with maximum safety to rectum and external sphincter.

Direx Korea is presently marketing the Tempro device in Korea.

About DirexGroup:
DirexGroup and Initia have created an alliance that specializes in introducing innovative high-technology treatment devices for urologists in all worldwide markets. DirexGroup, established over 20 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and services solutions to their clinical and economic needs. Our products are characterized by reliability, modularity, and transportability combined with cost effectiveness and ease of use. Worldwide network of committed service centers assure adequate support and maintenance

Contact DirexGroup at This email address is being protected from spambots. You need JavaScript enabled to view it.  

Page 7 of 8

Meet Us

Contact Us

© 2017 DirexGroup. All Rights Reserved.